Omanta
Omanta is a YC Summer 2026 (S26) company. Based in San Francisco, CA, USA. Team of 4.
About Omanta
Summary
Omanta runs a personalized research program for patients with cancer, rare diseases, or unresolved diagnoses who have run out of standard options. For each case, a dedicated team of PhD scientists collects clinical records, performs multiomic analysis, and builds a therapeutic roadmap, replacing the patchwork of one-off consultations and generic diagnostic workups those patients would otherwise navigate. Clinicians receive a continuously updated evidence base to guide treatment decisions for their most complex cases.
Go-to-market
Omanta serves both patients seeking direct engagement and oncologists managing complex cases, with entry through a conversation request rather than a self-serve signup, indicating a high-touch, case-by-case intake process.
From the Y Combinator listing
A research lab for one
Omanta is a personalized research lab for patients who have exhausted standard options, want to prepare proactively for recurrence, or are living with an unresolved diagnosis. We direct the full operational infrastructure, personnel, expertise, and technology of a large research program toward understanding and addressing the challenges of individual patients across oncology, rare disease, and undiagnosed conditions. For clinicians, we act as a collaborative partner, providing a living roadmap for ongoing patient care built on a rigorous and evolving scientific evidence base. We fully operationalize patient-specific research programs, covering tissue logistics, diagnostic follow-up, data integration, multiomic analysis, therapeutic strategy development, and more. Omanta brings context and clarity to complex cases, helping clinicians see more of the scientific picture as they decide how best to care for their patients.
Facts
- Healthcare / Healthcare
- San Francisco, CA, USA
- 4
- Active
- Early
Founders (2)
- Alfredo Gonzalez
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works